Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 484

1.

[Effect of intravenous granisetron combined and acupuncture point injection at PC6(Neiguan) with 0.9% sodium chlorideon postoperative nausea and vomiting after gynecological laparoscopy].

Yu Y, Fan H, Cheng Y, Sun JL.

Zhonghua Yi Xue Za Zhi. 2019 Sep 3;99(33):2606-2610. doi: 10.3760/cma.j.issn.0376-2491.2019.33.010. Chinese.

PMID:
31510721
2.

Efficacy of Palonosetron as Antiemetic Prophylaxis for Post Operative Patients.

Hossain MM, Begum M, Hossain M, Chowdhury MG, Begum R, Ahamed S, Shuvo FR.

Mymensingh Med J. 2019 Jan;28(1):222-229.

PMID:
30755573
3.

Pharmacokinetics and safety of transdermal and oral granisetron in healthy Chinese subjects: An open-label, randomized, crossover study‚Ä©.

Chen R, Chen X, Wang H, Zhong W, Oh ES, Park MS, Kumagai Y, Zhou L, Nagahama F, Hu P.

Int J Clin Pharmacol Ther. 2019 Jan;57(1):24-31. doi: 10.5414/CP203327.

PMID:
30336808
4.

Real-world efficacy: intravenous palonosetron three-drug regimen for chemotherapy-induced nausea and vomiting with highly emetogenic chemotherapy.

Schwartzberg LS, McLaughlin T, Geller RB, Gabrail NY, Marks SM.

J Comp Eff Res. 2018 Dec;7(12):1161-1170. doi: 10.2217/cer-2018-0089. Epub 2018 Oct 11.

5.

Risk factors associated with chemotherapy-induced nausea and vomiting in the triplet antiemetic regimen including palonosetron or granisetron for cisplatin-based chemotherapy: analysis of a randomized, double-blind controlled trial.

Tsuji D, Suzuki K, Kawasaki Y, Goto K, Matsui R, Seki N, Hashimoto H, Hama T, Yamanaka T, Yamamoto N, Itoh K.

Support Care Cancer. 2019 Mar;27(3):1139-1147. doi: 10.1007/s00520-018-4403-y. Epub 2018 Aug 10.

PMID:
30094732
6.

A phase 2 study of fosaprepitant combined with high-dose dexamethasone for Japanese cancer patients receiving highly emetogenic chemotherapy.

Kumagai H, Kusaba H, Yamanaka T, Nio K, Inadomi K, Takayoshi K, Ito M, Tamura S, Makiyama A, Makiyama C, Hirano G, Shibata Y, Shirakawa T, Mitsugi K, Ariyama H, Esaki T, Akashi K, Baba E.

Medicine (Baltimore). 2018 Jun;97(25):e11042. doi: 10.1097/MD.0000000000011042.

7.

[Electrothermal acupuncture in the prevention and treatment of chemotherapy-induced nausea and vomiting:a randomized controlled trial].

Lu D, Lu D, Bai D, He S, Wang F, Gao Y, Du Y, Wang N, Jiang Z, Wang Z, Zhu S.

Zhongguo Zhen Jiu. 2017 Apr 12;37(4):355-359. doi: 10.13703/j.0255-2930.2017.04.003. Chinese.

PMID:
29231584
9.

[Comparison of granisetron and lidocaine on reducing injection pain of etomidate: a controlled randomized study].

Saliminia A, Azimaraghi O, Javadi A, Abdoulahpoor M, Movafegh A.

Rev Bras Anestesiol. 2017 Nov - Dec;67(6):615-618. doi: 10.1016/j.bjan.2017.04.027. Epub 2017 Aug 18. Portuguese.

10.

Feasibility of olanzapine, multi acting receptor targeted antipsychotic agent, for the prevention of emesis caused by continuous cisplatin- or ifosfamide-based chemotherapy.

Bun S, Yonemori K, Akagi T, Noguchi E, Shimoi T, Shimomura A, Yunokawa M, Shimizu C, Fujiwara Y, Makino Y, Hayashi Y, Tamura K.

Invest New Drugs. 2018 Feb;36(1):151-155. doi: 10.1007/s10637-017-0487-3. Epub 2017 Jul 21.

PMID:
28733700
11.

Efficacy and safety of fosaprepitant in the prevention of nausea and vomiting following highly emetogenic chemotherapy in Chinese people: A randomized, double-blind, phase III study.

Yang LQ, Sun XC, Qin SK, Cheng Y, Shi JH, Chen ZD, Wang QM, Zhang HL, Hu B, Liu B, Zhang QY, Wu Q, Wang D, Shu YQ, Dong J, Han BH, Wang KM, Dang CX, Li JL, Wang HB, Li BL, Lu JG, Zhang ZH, Chen YX.

Eur J Cancer Care (Engl). 2017 Nov;26(6). doi: 10.1111/ecc.12668. Epub 2017 Apr 10.

12.

Transdermal granisetron for the prevention of nausea and vomiting following moderately or highly emetogenic chemotherapy in Chinese patients: a randomized, double-blind, phase III study.

Yang LQ, Sun XC, Qin SK, Chen YX, Zhang HL, Cheng Y, Chen ZD, Shi JH, Wu Q, Bai YX, Han BH, Liu W, Ouyang XN, Liu JW, Zhang ZH, Li YQ, Xu JM, Yu SY.

Chin Clin Oncol. 2016 Dec;5(6):79. doi: 10.21037/cco.2016.12.04.

13.

Influence of Polymorphisms in the HTR3A and HTR3B Genes on Experimental Pain and the Effect of the 5-HT3 Antagonist Granisetron.

Louca Jounger S, Christidis N, Hedenberg-Magnusson B, List T, Svensson P, Schalling M, Ernberg M.

PLoS One. 2016 Dec 21;11(12):e0168703. doi: 10.1371/journal.pone.0168703. eCollection 2016.

14.

Dexamethasone does not diminish sugammadex reversal of neuromuscular block - clinical study in surgical patients undergoing general anesthesia.

Rezonja K, Mars T, Jerin A, Kozelj G, Pozar-Lukanovic N, Sostaric M.

BMC Anesthesiol. 2016 Oct 21;16(1):101.

15.

Randomized, double-blind, phase III trial of palonosetron versus granisetron in the triplet regimen for preventing chemotherapy-induced nausea and vomiting after highly emetogenic chemotherapy: TRIPLE study.

Suzuki K, Yamanaka T, Hashimoto H, Shimada Y, Arata K, Matsui R, Goto K, Takiguchi T, Ohyanagi F, Kogure Y, Nogami N, Nakao M, Takeda K, Azuma K, Nagase S, Hayashi T, Fujiwara K, Shimada T, Seki N, Yamamoto N.

Ann Oncol. 2016 Aug;27(8):1601-6. doi: 10.1093/annonc/mdw220. Epub 2016 Jun 29.

PMID:
27358385
16.

Incompatibilities of lornoxicam with 4 antiemetic medications in polyolefin bags during simulated intravenous administration.

Fang BX, Li P, Shi XY, Chen FC, Wang LH.

Medicine (Baltimore). 2016 Jun;95(25):e3824. doi: 10.1097/MD.0000000000003824.

17.

Aprepitant, granisetron, and dexamethasone versus palonosetron and dexamethasone for prophylaxis of cisplatin-induced nausea and vomiting in patients with upper gastrointestinal cancer: a randomized crossover phase II trial (KDOG 1002).

Ishido K, Higuchi K, Azuma M, Sasaki T, Tanabe S, Katada C, Yano T, Wada T, Koizumi W; Kitasato Digestive Disease & Oncology Group.

Anticancer Drugs. 2016 Oct;27(9):884-90. doi: 10.1097/CAD.0000000000000385.

PMID:
27254283
18.

Sequential addition of aprepitant in patients receiving carboplatin-based chemotherapy.

Suzuki S, Karayama M, Inui N, Kuroishi S, Fujisawa T, Enomoto N, Nakamura Y, Yokomura K, Toyoshima M, Imokawa S, Asada K, Masuda M, Yamada T, Watanabe H, Hayakawa H, Suda T.

Med Oncol. 2016 Jul;33(7):65. doi: 10.1007/s12032-016-0780-6. Epub 2016 May 27.

PMID:
27235141
19.

Efficacy of the neurokinin-1 receptor antagonist rolapitant in preventing nausea and vomiting in patients receiving carboplatin-based chemotherapy.

Hesketh PJ, Schnadig ID, Schwartzberg LS, Modiano MR, Jordan K, Arora S, Powers D, Aapro M.

Cancer. 2016 Aug 1;122(15):2418-25. doi: 10.1002/cncr.30054. Epub 2016 May 13. Erratum in: Cancer. 2016 Nov 15;122(22):3579.

20.

Control of nausea with palonosetron versus granisetron, both combined with dexamethasone, in patients receiving cisplatin- or anthracycline plus cyclophosphamide-based regimens.

Kubota K, Saito M, Aogi K, Sekine I, Yoshizawa H, Yanagita Y, Sakai H, Inoue K, Kitagawa C, Ogura T.

Support Care Cancer. 2016 Sep;24(9):4025-33. doi: 10.1007/s00520-016-3203-5. Epub 2016 Apr 29.

Supplemental Content

Loading ...
Support Center